Duckweed Experiment Update
We are two days into the duckweed experiment and we ran into a slight problem. The air stone that we are using to aerate the water was producing bubbles at a rate that resulted in a slight current being formed by the bubbles outward motion on the surface of the water.
Duckweed likes a still surface to grow on and with the bubbles pushing the duckweed toward the outer edges of the duckweed bed, I knew that its growth may be hampered.
By taking an old, plastic bucket and cutting off the bottom, I was able to "catch" the bubbles and isolate the frothing into a confined area. With the now still surface being maintained, the duckweed has spread out and appears to be doing very well.
I wanted to take a quick second and post an update if there are any homesteaders out there that are thinking about following in my footsteps and making a duckweed bed.
This weekend I hope to post a video on a Black Solider Fly harvester and using PVC to water tomatoes and other plants. Have a great rest of the week.
We are two days into the duckweed experiment and we ran into a slight problem. The air stone that we are using to aerate the water was producing bubbles at a rate that resulted in a slight current being formed by the bubbles outward motion on the surface of the water.
Duckweed likes a still surface to grow on and with the bubbles pushing the duckweed toward the outer edges of the duckweed bed, I knew that its growth may be hampered.
By taking an old, plastic bucket and cutting off the bottom, I was able to "catch" the bubbles and isolate the frothing into a confined area. With the now still surface being maintained, the duckweed has spread out and appears to be doing very well.
I wanted to take a quick second and post an update if there are any homesteaders out there that are thinking about following in my footsteps and making a duckweed bed.
This weekend I hope to post a video on a Black Solider Fly harvester and using PVC to water tomatoes and other plants. Have a great rest of the week.
The first theme is introduced in the membrane-bound receptors, including epidermal growth factor receptor (EGFR) family of receptors, from Spain, from the University Hospital Vall Desi Buren (Vall d'Hebron University Hospital) in Dr.Josep Tabernero be described. Since 75% to 90% of CRC patients can be observed in the expression of EGFR and EGFR are indicators of poor prognosis, researchers in the EGFR family of receptors for a lot of work, so that cetuximab and Panitumumab is approved for the treatment of CRC KRAS wild-type, both of which are the scope of the extracellular region of EGFR monoclonal antibodies. Such new trial including GA201, SYM004 studies (SYM004 can degrade and removal of cell surface receptors), as well as cetuximab and immunomodulatory drugs to that degree by the combination. It also discusses other membrane-bound receptors, including insulin-like growth (ILG) factor receptor, platelet-derived growth factor receptor (PDGFR), HCF c-Met receptor ligand and tumor necrosis factor-related apoptosis-inducing ligand body (TRAIL) receptors.
ReplyDeleteSimilarly, in the CRC research is promising scope intracellular signal transduction pathway components of the drug, this topic from the United States University of Colorado Dr.Wells Messersmith introduced. He discussed the ongoing development of promising new drugs, these drugs act on the MAPK, PI3K, SRC, Notch and hebgehog signal transduction pathway. Many drugs currently being carried out for various types of cancer in stage Ⅰ and Ⅱ early clinical trials. Expect these promising new approach in the near future for the clinician to bring more treatment options.
Finally, from the University of Texas Cancer Center Dr.Scott Kopetz MDAnderson introduced for the treatment of CRC angiogenesis inhibitors. To anti-vascular endothelial growth factor monoclonal antibody bevacizumab high success rate of the treatment begins, Dr.Kopetz recalled from the first generation and second generation angiogenesis inhibitors such as vatalanib and cediranib treatment failure of lessons learned, noting grasp early in the drug development process VEGF inhibitors pharmacokinetic importance "Unfortunately, there is no evidence that in addition to bevacizumab other than anti-angiogenic drugs can provide meaningful clinical benefit," Dr.Kopetz said he proposed a possible exception.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
BAY 61-3606 dihydrochloride
E-3810
BAY 61-3606
Cabozantinib S-malate
Pazopanib
Axitinib
OSI-930
Cediranib
MP470
Motesanib Diphosphate